Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer
Chunhao Lin, Shoumin Bai, Tao Du, Yiming Lai, Xianju Chen, Shengmeng Peng, Xiaoming Ma, Wanhua Wu, Zhenghui Guo, Hai Huang.
Cancer Manag Res. 2019 Feb 14;11:1517-1524.
引用產(chǎn)品：abs830032 Anti-β-tubulin 抗體
影響因子：3.702
Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation
Zhu Wang, Jianhua Yin, Mingxing Li, Jing Shen, Zhangang Xiao, Yueshui Zhao, Chengliang Huang, Hanyu Zhang, Zhuo Zhang, Chi Hin Cho, Xu Wu.
Chinese Medicine. 2019 Mar 12.
引用產(chǎn)品：abs44070183 N-Acetyl-L-cysteine
影響因子：1.802
Neuropeptide W regulates proliferation and differentiation of ATDC5: Possible involvement of GPR7 activation, PKA and PKC‐dependent signalling cascades
RiKang Wang, Chaojun Zheng, Wenyu Jiang, Xinshu Xie, Rifang Liao, Guangqian Zhou.
J Cell Mol Med. 2019 Jan 04;23(3):2093-2102.
引用產(chǎn)品：abs133139 GPR7 Antibody
影響因子：4.302
Antioxidant and hepatoprotective activities of residue polysaccharides by Pleurotus citrinipileatus
Xinchao Liu, Hui Pang, Zheng Gao, Huajie Zhao, Jianjun Zhang, Le Jia.
Int J Biol Macromol. 2019 Jan 15;131:315-322.
引用產(chǎn)品：abs20002 goat anti-rabbit IgG-HRP
影響因子：3.909
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)
會(huì)員.png)
9
立即詢(xún)價(jià)
您提交后，專(zhuān)屬客服將第一時(shí)間為您服務(wù)